Timothy Fong, MD.
Clinical Professor of Psychiatry and Biobehavioral Sciences; Co-Director, Gambling Studies Program; David Geffen School of Medicine at UCLA, Los Angeles, CA.
Dr. Fong receives research support from Connections in Recovery. Relevant financial relationships listed for the author have been mitigated.
Michael J. Gitlin, MD.
Professor of Clinical Psychiatry and Director of the Mood Disorders Clinic at the David Geffen School of Medicine at UCLA; coauthor of The Essential Guide to Lithium Treatment (Springer, 2016).
Dr. Gitlin has no financial relationships with companies related to this material.
Caridad Ponce Martinez, MD, FAPA, FASAM.
Assistant professor of psychiatry, UMass Chan Medical School, Worcester, MA.
Dr. Ponce Martinez has no financial relationships with companies related to this material.
Nicholas Athanasiou, MD, MBA, DFASAM.
Associate clinical professor, Psychiatry and Biobehavioral Sciences (DGSOM), UCLA Olive View Psychiatry Residency Program; Supervising Mental Health Psychiatrist, Los Angeles County Department of Mental Health, Los Angeles, CA.
Dr. Athanasiou has no financial relationships with companies related to this material.
Kathryn Martin, MD, MPH. Dr. Martin discloses that she owns shares in a variety of pharmaceutical companies. Relevant financial relationships listed for the author have been mitigated.
Marilyn C. Jones, MD
Clinical Service Chief, Genetics, Rady Children’s Hospital-San Diego; Distinguished Professor of Clinical Pediatrics, UCSD, San Diego, CA.
Dr. Jones has no financial relationships with companies related to this material.
Ira J. Chasnoff, MD.
Professor of Clinical Pediatrics, University of Illinois College of Medicine, Chicago, IL; President, NTI Upstream, Chicago, IL.
Dr. Chasnoff’s company, NTI Upstream, receives a licensing fee for the 4Ps Plus© screening instrument. Relevant financial relationships listed for the author have been mitigated.
David Healy, MD, FRCPsych. Chief Scientific Officer, Data Based Medicine Ltd, Bangor, Wales, UK.
Dr. Healy has no financial relationships with companies related to this material.
Aaron Greenstein, MD.
Geriatric psychiatrist in private practice, Denver, CO. Dr. Greenstein is a medical advisor for BrainCheck, Sensi.AI, and Optimize VBC. He is a consultant for GE Healthcare and LEK Consulting.
Relevant financial relationships listed for the author have been mitigated.
Thomas Schwartz, MD.
Professor and Chair, Department of Psychiatry and Behavioral Sciences, Alan and Marlene Norton College of Medicine, SUNY Upstate Medical University, Syracuse, NY.
Dr. Schwartz has no financial relationships with companies related to this material.
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.jpg?1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
RSS
